Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagdeep Shur

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Drug Development and Industrial Pharmacy|July 16, 2008
The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approachJennifer C Hooton, Matthew D Jones, Haggis Harris, et al.
International Journal of Pharmaceutics|March 18, 2008
The use of atomic force microscopy to study the conditioning of micronised budesonideMatthew D Jones, Paul M Young, Daniela Traini, et al.
Journal of Pharmaceutical Sciences|December 11, 2008
The role of force control agents in high-dose dry powder inhaler formulationsPhilippe Begat, David A V Morton, Jagdeep Shur, et al.
International Journal of Pharmaceutics|June 6, 2016
From single excipients to dual excipient platforms in dry powder inhaler productsJagdeep Shur, Robert Price, David Lewis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 11, 2007
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosisVictoria J Broughton-Head, Jagdeep Shur, Mary P Carroll, et al.
Pharmaceutical Research|October 7, 2024
Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical TechniquesGonçalo Farias, William J Ganley, Robert Price, et al.
The AAPS Journal|February 16, 2020
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug ProductsRobert Price, Jagdeep Shur, William Ganley, et al.
Journal of Pharmaceutical Sciences|March 21, 2008
Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapyJagdeep Shur, Thomas G Nevell, Richard J Ewen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 15, 2008
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balancesMatthew D Jones, Haggis Harris, Jennifer C Hooton, et al.
Molecular Pharmaceutics|September 29, 2023
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal SpraysElham Amini, Simon M Berger, Uta Schilling, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Drug Development and Industrial Pharmacy|July 16, 2008
The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approachJennifer C Hooton, Matthew D Jones, Haggis Harris, et al.
International Journal of Pharmaceutics|March 18, 2008
The use of atomic force microscopy to study the conditioning of micronised budesonideMatthew D Jones, Paul M Young, Daniela Traini, et al.
Journal of Pharmaceutical Sciences|December 11, 2008
The role of force control agents in high-dose dry powder inhaler formulationsPhilippe Begat, David A V Morton, Jagdeep Shur, et al.
International Journal of Pharmaceutics|June 6, 2016
From single excipients to dual excipient platforms in dry powder inhaler productsJagdeep Shur, Robert Price, David Lewis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 11, 2007
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosisVictoria J Broughton-Head, Jagdeep Shur, Mary P Carroll, et al.
Pharmaceutical Research|October 7, 2024
Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical TechniquesGonçalo Farias, William J Ganley, Robert Price, et al.
The AAPS Journal|February 16, 2020
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug ProductsRobert Price, Jagdeep Shur, William Ganley, et al.
Journal of Pharmaceutical Sciences|March 21, 2008
Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapyJagdeep Shur, Thomas G Nevell, Richard J Ewen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 15, 2008
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balancesMatthew D Jones, Haggis Harris, Jennifer C Hooton, et al.
Molecular Pharmaceutics|September 29, 2023
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal SpraysElham Amini, Simon M Berger, Uta Schilling, et al.
Pageof 4